Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > I pulled this from Yahoo discussion group re Aezs

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Feb 01, 2024 2:19pm

62 Views

Post# 35857687

RE:RE:I pulled this from Yahoo discussion group re Aezs

Ciao, "They want to trick you into thinking it’s in our best interest for a reverse split when actually the lesser of the 2 evils is to get delisted from nasdaq as clearly trading at 0.20 cents we aren’t visible anyway..."

It's interestng to watch Ciao struggle with his investment. If you ever wanted to know why you can make a lot of money in microcap stocks its because of people like Ciao. He is incapable of looking at where the puck is going. He's obsessed with where the puck is in the moment and where it was. After a decade of development Gilles wants the pipeline on the NASDAQ now. This is the moment we've been waiting for. Gilles wants this listing with Ronnie Miller, Natex, Dr. Tardif, Dr. Li, Dr. Kolb, and Boom Burton by his side. Major events are upon the company refered to as the daisy chian. AEZS has also been grooming a portfolio to the point of go/no go clinical trial decisions and the licesning and launch of its diagnostic test; including for the most important market(children). Gilles has placed himself on the inside of AEZS for a view in the catbird seat. Ciao can't see any of this.

There has never been a moment like this in CZO's history. The daisy chain is before the company an with the merger it will be fully financed and potentially with analysts.

The path,
the daisy chain of events that will define this merger...

AEZS's diagnostic test clinical trial results for children
Launch of powder formulations of CZO's two active ingredients(beta glucan, avenanthramide)
CZO's main client returns
AEZS's diagnostic continuing roll-out for adults
FDA approval for the test for children
Licensing deal for the diagnostic test for North America
Commissioning of 5X PGX scale-up
Commissioning of 10X scale-up to decision point for mass industrialization of PGX
PGX licensing deal
Immune booster plant
Phase I avenanthramide clinical trial results
Wound healing results
Wound healing partnership
Fibrosis clinical trial 'go'/'no go' decision and regulatory filing
Phase IIa avenanthramide clinical trial results
Avenanthramide pill partnership
AIM Biologicals 'go'/'no go' clinical trial decision

Image result for daisy chain fireworks